Biology Reference
In-Depth Information
49. Chandrachud LM, Grindlay GJ, McGarvie GM,
et al
. (1995)
Vaccination of cattle with the N-terminus of L2 is necessary and suffi-
cient for preventing infection by bovine papillomavirus-4.
Virology
211
: 204-208.
50. Embers ME, Budgeon LR, Pickel M, Christensen ND. (2002)
Protective immunity to rabbit oral and cutaneous papillomaviruses by
immunization with short peptides of L2, the minor capsid protein.
J Virol
76
: 9798-9805.
51. Evans TG, Bonnez W, Rose RC,
et al
. (2001) A Phase 1 study of a
recombinant virus-like particle vaccine against human papillomavirus
type 11 in healthy adult volunteers.
J Infect Dis
183
: 1485-1493.
52. Harro CD, Pang YY, Roden RB,
et al
. (2001) Safety and immuno-
genicity trial in adult volunteers of a human papillomavirus type 16 L1
virus-like particle vaccine.
J Natl Cancer Inst
93
: 284-292.
53. Schiller JT, Davies P. (2004) Delivering on the promise: HPV vaccines
and cervical cancer.
Nature Rev Microbiology
2
: 343-347.
54. Kawana K, Yasugi T, Kanda T,
et al
. (2003) Safety and immunogenicity
of a peptide containing the cross-neutralization epitope of HPV16 L2
administered nasally in healthy volunteers.
Vaccine
21
: 4256-4260.